GOUT AND HYPERURICEMIA
Clinical trials for GOUT AND HYPERURICEMIA explained in plain language.
Never miss a new study
Get alerted when new GOUT AND HYPERURICEMIA trials appear
Sign up with your email to follow new studies for GOUT AND HYPERURICEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Diabetes drug could be new weapon against gout pain
Disease control Not yet recruitingThis study is testing if a medication called empagliflozin, commonly used for diabetes, can help control gout. Researchers will give the drug or a placebo to 60 adults with gout for 12 weeks to see if it lowers uric acid levels and reduces inflammation. The goal is to gather evid…
Matched conditions: GOUT AND HYPERURICEMIA
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New pill tested to tame painful gout flares
Disease control Not yet recruitingThis study is testing a new oral medication called BR2251 to see if it can safely lower high uric acid levels in people with gout. Researchers will compare three different doses of BR2251 against a standard gout medication over 12 weeks in 160 participants. The main goal is to fi…
Matched conditions: GOUT AND HYPERURICEMIA
Phase: PHASE2 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
DNA test could stop deadly drug reactions for gout patients
Prevention Not yet recruitingThis study aims to prevent severe, life-threatening skin reactions in people with gout who are starting a common medication called allopurinol. Researchers will test patients for a specific gene (HLA-B58:01) that increases the risk of these dangerous reactions. Patients with the …
Matched conditions: GOUT AND HYPERURICEMIA
Phase: PHASE4 • Sponsor: Haiphong University of Medicine and Pharmacy • Aim: Prevention
Last updated Apr 04, 2026 06:35 UTC